Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials

Rezultati

Naziv:	Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials
Autori:	Afzali, Anita; Panes, Julian; Sands, Bruce E; Rubin, David T; Panaccione, Remo; Terry, Natalie A; Salese, Leonardo; Van, Rampelbergh Rian; Yang, Zijiang; Frustaci, Mary Ellen; Tarabar, Dino K; Chen, Minhu; Mihaly, Emese; Wolf, Douglas; D'Haens, Geert R;
Godina:	2024
Publikacija:	AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN:	0002-9270 American Journal of Gastroenterology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 119 br. 10S str. S1024-S1025
DOI:	10.14309/01.ajg.0001035084.95280.e1
WoS-ID:	001359341300005
URI:	https://enauka.gov.rs/handle/123456789/952780
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Alt metrika

Dimensions

Unpaywall

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.